ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

ANVS Annovis Bio Inc

13,10
1,22 (10,27%)
25 Apr 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Annovis Bio Inc ANVS NYSE Common Stock
  Änderung Änderung % Aktuell Zeit
1,22 10,27% 13,10 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
11,99 11,985 13,6499 12,74 11,88
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
02.4.202413:30GLOBEAnnovis Bio Provides Corporate Updates and Reports Fourth..
28.2.202413:08IHMARKETNEWSUS Stock Movers Before Market: Beyond Meat, eBay, First..
12.2.202420:00EDGAR2Form S-3/A - Registration statement under Securities Act of..
01.2.202422:05EDGAR2Form S-3 - Registration statement under Securities Act of..
22.11.202322:27EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
21.11.202320:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.11.202320:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.11.202320:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.11.202320:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.11.202322:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02.11.202312:30BWAnnovis Bio Measures Novel Biomarkers in Plasma of..
01.11.202317:28EDGAR2Form 8-K - Current report
01.11.202317:24EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
31.10.202313:00BWAnnovis Bio Announces Pricing of $7.5 Million Public..
30.10.202322:27EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
30.10.202322:17EDGAR2Form 8-K - Current report
30.10.202321:48BWAnnovis Bio Announces Launch of Proposed Public Offering
30.10.202321:42BWAnnovis Bio Receives Positive Recommendation to Continue..
24.10.202315:13BWAnnovis Bio Showcases Promising Progress in Novel Drug..
21.9.202315:35GLOBEDawson James Securities Announces October Date for 8th..
15.8.202313:20BWAnnovis Bio Announces Second Quarter 2023 Financial Results..
14.8.202322:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
18.7.202314:18BWContinued Positive Performance of Novel Drug Development by..
27.6.202313:30BWAnnovis Bio Announces the Filing of a Groundbreaking Patent
20.6.202318:05BWAnnovis Bio Receives Excellent Safety Rating and Positive..
08.6.202313:30PRNUSAnnovis Bio Announces Completion of Phase III Parkinson's..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock